tooluniverse-clinical-trial-matching

Transform patient molecular profiles and clinical characteristics into prioritized clinical trial recommendations. Searches ClinicalTrials.gov and cross-references with molecular databases (CIViC, OpenTargets, ChEMBL, FDA) to produce evidence-graded, scored trial matches.

| Gene + amino acid change | Specific mutation | EGFR L858R | | Gene + exon notation | Exon-level alteration | EGFR exon 19 deletion | | Gene + fusion partner | Fusion | EML4-ALK fusion | | Gene + amplification | Copy number gain | HER2 amplification | | Gene + expression level | Expression biomarker | PD-L1 50% |

| Gene + status | Status biomarker | MSI-high, TMB-high | | Gene + resistance | Resistance mutation | EGFR T790M |

AI-driven patient-to-trial matching for precision medicine and oncology. Given a patient profile (disease, molecular alterations, stage, prior treatments), discovers and ranks clinical trials from ClinicalTrials.gov using multi-dimensional matching across molecular eligibility, clinical criteria, drug-biomarker alignment, evidence strength, and geographic feasibility. Produces a quantitative Trial Match Score (0-100) per trial with tiered recommendations and a comprehensive markdown report. Use when oncologists, molecular tumor boards, or patients ask about clinical trial options for specific cancer types, biomarker profiles, or post-progression scenarios. Source: mims-harvard/tooluniverse.